Speaker illustration

Professor Harry Crijns

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))

Graduated in medicine at the University of Amsterdam in 1981, he completed his cardiology training at the University Medical Centre Groningen, The Netherlands in 1987, where he continued working as clinical cardiologist and electrophysiologist. He obtained a PhD at the University of Groningen in 1993 on 'Changes of Intracardiac Conduction Induced by Anti-arrhythmic Drugs - Importance of Use and Reverse Use-dependence'. He currently is emeritus professor of Cardiology, Maastricht University and Cardiovascular research Institute Maastricht (CARIM). Contributions to the field include improved rate/rhythm control (RACE-trials, HATCH score), stroke prevention (CHA2DS2-VASc) and bleeding in AF (HAS-BLED). Current interests: idiopathic AF, atherothrombotic mechanisms in AF progression; hybrid AF ablation; early rhythm control in high risk AF.

Ask the Trialists from Hot Lines 6 and 7

Event: ESC Congress 2023

Topic: European Society of Cardiology

Session type: Ask the Trialists

Thumbnail

EHRA Tracing - ECG - Day 1

Event: EHRA 2023

Topic: Electrocardiography (ECG)

Session type: Special Session

Thumbnail

Atrial Fibrillation - Round 1 - Drugs, Prevention

Event: EHRA 2023

Topic: Atrial Fibrillation (AF)

Session type: Abstract Sessions

Thumbnail

The year in 2022

Event: EHRA 2023

Topic: Arrhythmias, General

Session type: Symposium

Thumbnail

Hybrid ablation: atrial fibrillation and beyond

Event: EHRA 2023

Topic: Treatment

Session type: Satellite Symposium

Thumbnail

Moderated ePosters - Basics of arrhythmias

Event: EHRA 2022

Topic: Cardiac Diseases

Session type: Moderated Posters

Thumbnail

Hein Wellens Memorial ECG session

Event: EHRA 2022

Topic: Electrocardiography (ECG)

Session type: Special Session

Thumbnail

ECG competition

Event: EHRA 2022

Topic: Electrocardiography (ECG)

Session type: Special Session

Thumbnail

Atrial arrhythmias and anticoagulation: challenging clinical scenarios

Event: ESC Congress 2021 - The Digital Experience

Topic: Atrial Fibrillation (AF)

Session type: Symposium

Thumbnail

EHRA practical guide to NOAC use in atrial fibrillation

Event: EHRA 2021

Topic: Oral Anticoagulation

Session type: Special Session

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb